Questions Regarding Frontline Therapy of Acute Myeloid Leukemia

被引：36
作者：
Kantarjian, Hagop [1 ]
O'Brien, Susan [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Leukemia Dept, Houston, TX 77030 USA
来源：
CANCER | 2010年 / 116卷 / 21期
关键词：
RANDOMIZED-TRIALS; DOUBLE INDUCTION; OLDER PATIENTS; AML; CHEMOTHERAPY; CYTARABINE; DAUNORUBICIN; IDARUBICIN; ADULTS; AGE;
D O I：
10.1002/cncr.25281
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：4896 / 4901
页数：6
相关论文
共 24 条
[1]   Monosomal karyotype in acute myeloid leukemia:: A better indicator of poor prognosis than a complex karyotype [J].
Breems, Dimitri A. ;
Van Putten, Wim L. J. ;
De Greef, Georgine E. ;
Van Zelderen-Bhola, Shama L. ;
Gerssen-Schoorl, Klasien B. J. ;
Mellink, Clemens H. M. ;
Nieuwint, Aggie ;
Jotterand, Martine ;
Hagemeijer, Anne ;
Beverloo, H. Berna ;
Lowenberg, Bob .
JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (29) :4791-4797
[2]  
Büchner T, 1999, BLOOD, V93, P4116
[3]   Quantitative DNA methylation predicts survival in adult acute myeloid leukemia [J].
Bullinger, Lars ;
Ehrich, Mathias ;
Doehner, Konstanze ;
Schlenk, Richard F. ;
Doehner, Hartmut ;
Nelson, Matthew R. ;
van den Boom, Dirk .
BLOOD, 2010, 115 (03) :636-642
[4]  
Burnett AK, 2009, BLOOD, V114, P200
[5]   Intensified induction chemotherapy in adult acute myeloid leukemia followed by high-dose chemotherapy and autologous peripheral blood stem cell transplantation: an Eastern Cooperative Oncology Group trial (E4995) [J].
Cassileth, PA ;
Lee, SJ ;
Litzow, MR ;
Miller, KB ;
Stadtmauer, EA ;
Tallman, MS ;
Lazarus, HM ;
Bennett, JM ;
Paietta, E ;
Dewald, GW ;
Rowe, JM .
LEUKEMIA & LYMPHOMA, 2005, 46 (01) :55-61
[6]   Randomized comparison of double induction and timed-sequential induction to a "3+7" induction in adults with AML:: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study [J].
Castaigne, S ;
Chevret, S ;
Archimbaud, E ;
Fenaux, P ;
Bordessoule, D ;
Tilly, H ;
de Revel, T ;
Simon, M ;
Dupriez, B ;
Renoux, M ;
Janvier, M ;
Micléa, JM ;
Thomas, X ;
Bastard, C ;
Preudhomme, C ;
Bauters, F ;
Degos, L ;
Dombret, H .
BLOOD, 2004, 104 (08) :2467-2474
[7]   Anthracycline Dose Intensification in Acute Myeloid Leukemia [J].
Fernandez, Hugo F. ;
Sun, Zhuoxin ;
Yao, Xiaopan ;
Litzow, Mark R. ;
Luger, Selina M. ;
Paietta, Elisabeth M. ;
Racevskis, Janis ;
Dewald, Gordon W. ;
Ketterling, Rhett P. ;
Bennett, John M. ;
Rowe, Jacob M. ;
Lazarus, Hillard M. ;
Tallman, Martin S. .
NEW ENGLAND JOURNAL OF MEDICINE, 2009, 361 (13) :1249-1259
[8]   Attempts to improve treatment outcomes in acute myeloid leukemia (AML) in older patients: the results of the United Kingdom Medical Research Council AML11 trial [J].
Goldstone, AH ;
Burnett, AK ;
Wheatley, K ;
Smith, AG ;
Hutchinson, RM ;
Clark, RE .
BLOOD, 2001, 98 (05) :1302-1311
[9]   Heterogeneity in the AML stem cell pool [J].
Hays, Laura E. .
BLOOD, 2009, 114 (19) :3976-3977
[10]   Modeling the functional heterogeneity of leukemia stem cells: role of STAT5 in leukemia stem cell self-renewal [J].
Heuser, Michael ;
Sly, Laura M. ;
Argiropoulos, Bob ;
Kuchenbauer, Florian ;
Lai, Courteney ;
Weng, Andrew ;
Leung, Malina ;
Lin, Grace ;
Brookes, Christy ;
Fung, Stephen ;
Valk, Peter J. ;
Delwel, Ruud ;
Loewenberg, Bob ;
Krystal, Gerald ;
Humphries, R. Keith .
BLOOD, 2009, 114 (19) :3983-3993
123